Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Unearned Common Stock held by the ESOP Cumulative Effect, Period of Adoption, Adjusted Balance	Unearned Common Stock held by the ESOP	Retained Earnings Cumulative effect of change in accounting principle	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Accumulated Other Comprehensive Loss Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Loss	Cumulative effect of change in accounting principle	Cumulative Effect, Period of Adoption, Adjusted Balance	Total
Balance at Dec. 31, 2022	$ 113	$ 113	$ 47,075	$ 47,075	$ (3,491)	$ (3,491)	$ (633)	$ 95,991	$ 96,624	$ (32,189)	$ (32,189)	$ (633)	$ 107,499	$ 108,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income									798					798
Other comprehensive income (loss)											2,221			2,221
ESOP shares committed to be allocated				(5)		54								49
Share-based compensation expense				150										150
Balance at Mar. 31, 2023		113		47,220		(3,437)			96,789		(29,968)			110,717
Balance at Dec. 31, 2023		111		45,959		(3,273)			100,386		(29,498)			113,685
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income									1,121					1,121
Other comprehensive income (loss)											(580)			(580)
ESOP shares committed to be allocated				(8)		54								46
Balance at Mar. 31, 2024		$ 111		$ 45,951		$ (3,219)			$ 101,507		$ (30,078)			$ 114,272